Boston Partners
SYNH

Boston Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Boston Partners’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-248,969
Closed -$10.5M – 770
2023
Q2 		$10.5M Sell
248,969
-523,802
-68% -$21.2M 0.01% 365
2023
Q1 		$28M Sell
772,771
-369,399
-32% -$13.4M 0.04% 275
2022
Q4 		$42.1M Buy
1,142,170
+126,649
+12% +$5.01M 0.06% 229
2022
Q3 		$48.3M Buy
1,015,521
+171,060
+20% +$11M 0.07% 220
2022
Q2 		$61.3M Buy
844,461
+74,026
+10% +$5.41M 0.09% 212
2022
Q1 		$62.8M Buy
770,435
+1,281
+0.2% +$108K 0.08% 218
2021
Q4 		$78.3M Sell
769,154
-147,031
-16% -$14.1M 0.09% 212
2021
Q3 		$80.3M Sell
916,185
-13,654
-1% -$1.24M 0.1% 217
2021
Q2 		$83.5M Sell
929,839
-50,448
-5% -$4.26M 0.11% 216
2021
Q1 		$75.6M Sell
980,287
-34,581
-3% -$2.61M 0.1% 225
2020
Q4 		$69.1M Sell
1,014,868
-56,093
-5% -$3.5M 0.11% 214
2020
Q3 		$56.9M Sell
1,070,961
-189,965
-15% -$11.3M 0.1% 218
2020
Q2 		$73.4M Sell
1,260,926
-157,265
-11% -$8.45M 0.13% 192
2020
Q1 		$55.6M Buy
1,418,191
+119,814
+9% +$7.01M 0.11% 204
2019
Q4 		$77.2M Sell
1,298,377
-76,228
-6% -$4.1M 0.1% 211
2019
Q3 		$73M Sell
1,374,605
-87,707
-6% -$4.5M 0.1% 211
2019
Q2 		$74.6M Buy
1,462,312
+426,193
+41% +$19.8M 0.1% 211
2019
Q1 		$53.6M Buy
1,036,119
+205,892
+25% +$9.98M 0.07% 231
2018
Q4 		$32.7M Buy
830,227
+53,562
+7% +$2.49M 0.05% 267
2018
Q3 		$40M Buy
776,665
+43,509
+6% +$2.13M 0.05% 263
2018
Q2 		$34.4M Buy
733,156
+28,205
+4% +$1.17M 0.04% 287
2018
Q1 		$25M Buy
704,951
+7,771
+1% +$304K 0.03% 310
2017
Q4 		$30.4M Buy
+697,180
New +$32.6M 0.04% 288

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Boston Partners's SYNH Position: Q3 2023 in Review

Boston Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 248,969 shares — an estimated $10.5M sold.

Boston Partners first reported a position in SYNH in Q4 2017 and held it in 23 quarters. The position peaked at $83.5M in Q2 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Boston Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Boston Partners sold 248,969 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $10.5M.
  • Boston Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2017 and held it in 23 quarters.
  • Boston Partners's Syneos Health, Inc. Class A Common Stock position peaked at $83.5M in Q2 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Boston Partners's 13F filing for Q3 2023, filed 8 Nov 2023.